Adamas Pharmaceuticals, Inc. (ADMS) Stock Analysis
DELISTED
What happened to Adamas Pharmaceuticals, Inc. (ADMS) stock?
Adamas Pharmaceuticals, Inc. (ADMS) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Adamas Pharmaceuticals, Inc. (ADMS). Adamas Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing therapies for chronic neurological disorders. Their key product is GOCOVRI, used for treating dyskinesia in Parkinson's disease patients.
Last analyzed: Mar 16, 2026Adamas Pharmaceuticals, Inc. (ADMS) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ADMS shares?
No. ADMS stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ADMS elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ADMS stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Adamas Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.